TY - JOUR
T1 - Vasopressin improves vital organ blood flow after prolonged cardiac arrest with postcountershock pulseless electrical activity in pigs
AU - Wenzel, Volker
AU - Lindner, Karl H.
AU - Prengel, Andreas W.
AU - Maier, Christopher
AU - Voelckel, Wolfgang
AU - Lurie, Keith G.
AU - Strohmenger, Hans U.
PY - 1999
Y1 - 1999
N2 - Objective: Although a benefit of vasopressin when compared with epinephrine was shown during cardiopulmonary resuscitation (CPR) after a short duration of ventricular fibrillation cardiac arrest, the effect of vasopressin during prolonged cardiac arrest with pulseless electrical activity is currently unknown. Design: Prospective, randomized laboratory investigation using an established porcine model with instrumentation for measurement of hemodynamic variables, vital organ blood flow, blood gases, and return of spontaneous circulation. Setting: University hospital laboratory. Subjects: Eighteen domestic pigs. Interventions: After 15 mins of cardiac arrest and 3 mins of chest compressions, 18 animals were randomly treated with either 0.8 units/kg vasopressin (n = 9) or 200 μg/kg epinephrine (n = 9). Measurements and Main Results: Compared with epinephrine, vasopressin resulted, at both 90 secs and 5 mins after drug administration, in significantly higher (p < .05) median (25th-75th percentiles) left ventricular myocardial blood flow (120 [range, 96193] vs. 54 [range, 11-92] and 56 [range, 41-80] vs. 21 [range, 1140] mL/min/100 g, respectively) and total cerebral blood flow (85 [78-102] vs. 24 [18-41] and 50 [44-52] vs. 8 [5-23] mL/min/100 g, respectively). Spontaneous circulation was restored in eight of nine animals in the vasopressin group and in one of nine animals in the epinephrine group (p= .003). Conclusions: Compared with a maximum dose of epinephrine, vasopressin significantly increased left ventricular myocardial and total cerebral blood flow during CPR and return of spontaneous circulation in a porcine model of prolonged cardiac arrest with postcountershock pulseless electrical activity.
AB - Objective: Although a benefit of vasopressin when compared with epinephrine was shown during cardiopulmonary resuscitation (CPR) after a short duration of ventricular fibrillation cardiac arrest, the effect of vasopressin during prolonged cardiac arrest with pulseless electrical activity is currently unknown. Design: Prospective, randomized laboratory investigation using an established porcine model with instrumentation for measurement of hemodynamic variables, vital organ blood flow, blood gases, and return of spontaneous circulation. Setting: University hospital laboratory. Subjects: Eighteen domestic pigs. Interventions: After 15 mins of cardiac arrest and 3 mins of chest compressions, 18 animals were randomly treated with either 0.8 units/kg vasopressin (n = 9) or 200 μg/kg epinephrine (n = 9). Measurements and Main Results: Compared with epinephrine, vasopressin resulted, at both 90 secs and 5 mins after drug administration, in significantly higher (p < .05) median (25th-75th percentiles) left ventricular myocardial blood flow (120 [range, 96193] vs. 54 [range, 11-92] and 56 [range, 41-80] vs. 21 [range, 1140] mL/min/100 g, respectively) and total cerebral blood flow (85 [78-102] vs. 24 [18-41] and 50 [44-52] vs. 8 [5-23] mL/min/100 g, respectively). Spontaneous circulation was restored in eight of nine animals in the vasopressin group and in one of nine animals in the epinephrine group (p= .003). Conclusions: Compared with a maximum dose of epinephrine, vasopressin significantly increased left ventricular myocardial and total cerebral blood flow during CPR and return of spontaneous circulation in a porcine model of prolonged cardiac arrest with postcountershock pulseless electrical activity.
KW - Blood flow
KW - Cardiopulmonary resuscitation
KW - Cerebrum
KW - Epinephrine
KW - Myocardium
KW - Pulseless electrical activity
KW - Return of spontaneous circulation
KW - Vasopressin
UR - http://www.scopus.com/inward/record.url?scp=0032959761&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032959761&partnerID=8YFLogxK
U2 - 10.1097/00003246-199903000-00022
DO - 10.1097/00003246-199903000-00022
M3 - Review article
C2 - 10199526
AN - SCOPUS:0032959761
SN - 0090-3493
VL - 27
SP - 486
EP - 492
JO - Critical care medicine
JF - Critical care medicine
IS - 3
ER -